glp-1 news employers CT Health | are facing mounting pressure from the growing cost of covering weight-loss drugs, as demand for medications like Wegovy and employers may drop GLP-1 coverage
Description
Mounjaro Wegovy Wegovy is the new injectable treatment for weight loss

methodology B.M.-R., L.B.-P., A.O.-C

Source: Polaris Market Research Analysis Regional Analysis The report provides market insights into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Activation of anxiogenic circuits instigates resistance to diet-induced obesity via increased energy expenditure

J Am Coll Cardiol (2020) 75(16):195674

Exploring the associated genetic causes of diabetic retinopathy as a Model of inflammation in retinal diseases
